Cardiovascular manifestations of rheumatologic diseasesROMAN, Mary J; SALMON, Jane E.Circulation (New York, N.Y.). 2007, Vol 116, Num 20, pp 2346-2355, issn 0009-7322, 10 p.Article

Surrogate markers for cardiovascular disease : Functional markersCOHN, Jay N; QUYYUMI, Arshed A; HOLLENBERG, Norman K et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 31-46, issn 0009-7322, 16 p., SUPArticle

Surrogate markers for cardiovascular disease : Structural markersMANCINI, G. B; DAHLÖF, Bjorn; DIEZ, Javier et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 22-30, issn 0009-7322, 9 p., SUPArticle

Air pollution and cardiovascular diseaseFRANCHINI, Massimo; MANNUCCI, Pier Mannuccio.Thrombosis research. 2012, Vol 129, Num 3, pp 230-234, issn 0049-3848, 5 p.Conference Paper

Statin Therapy—Part II: Clinical Considerations for Cardiovascular DiseaseSADOWITZ, Benjamin; SEYMOUR, Keri; COSTANZA, Michael J et al.Vascular and endovascular surgery. 2010, Vol 44, Num 6, pp 421-433, issn 1538-5744, 13 p.Article

LDL-cholestérol et maladies cardiovasculairesBRUCKERT, E.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 36-38, issn 1261-694X, 3 p.Article

Baseline ICAM-1 and VCAM-1 Are Increased in Initially Healthy Middle-Aged Men Who Develop Cardiovascular Disease During 6.6 Years of Follow-UpSCHMIDT, Caroline; HULTHE, Johannes; FAGERBERG, Bjorn et al.Angiology. 2009, Vol 60, Num 1, pp 108-114, issn 0003-3197, 7 p.Article

Statin Therapy—Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseSADOWITZ, Benjamin; MAIER, Kristopher G; GAHTAN, Vivian et al.Vascular and endovascular surgery. 2010, Vol 44, Num 4, pp 241-251, issn 1538-5744, 11 p.Article

Physical Activity and Cardiovascular Disease Prevention : Current RecommendationsKOKKINOS, Peter.Angiology. 2008, Vol 59, issn 0003-3197, 28S-29S, SUP2Conference Paper

The Impact of Prevention on Reducing the Burden of Cardiovascular DiseaseKAHN, Richard; ROBERTSON, Rose Marie; SMITH, Robert et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 5, pp 576-585, issn 0009-7322, 10 p.Article

Glucocorticoids and cardiovascular diseaseWALKER, Brian R.European journal of endocrinology. 2007, Vol 157, Num 5, pp 545-559, issn 0804-4643, 15 p.Article

Polyphénols et maladies cardiovasculairesBROUSTET, J.-P.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 32-35, issn 1261-694X, 4 p.Conference Paper

Adipocytokines in relation to cardiovascular diseaseVAN DE VOORDE, Johan; PAUWELS, Bart; BOYDENS, Charlotte et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 11, pp 1513-1521, issn 0026-0495, 9 p.Article

Medication Adherence in Cardiovascular DiseaseBAROLETTI, Steven; DELL'ORFANO, Heather.Circulation (New York, N.Y.). 2010, Vol 121, Num 12, pp 1455-1458, issn 0009-7322, 4 p.Article

Novel Peptide Isomer Strategy for Stable Inhibition of Catecholamine Release Application to HypertensionBISWAS, Nilima; GAYEN, Jiaur; MAHATA, Manjula et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 60, Num 6, pp 1552-1559, issn 0194-911X, 8 p.Article

Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseZENENG WANG; KLIPFELL, Elizabeth; YUPING WU et al.Nature (London). 2011, Vol 472, Num 7341, pp 57-63, issn 0028-0836, 7 p.Article

The Polypill in the Prevention of Cardiovascular Diseases Key Concepts, Current Status, Challenges, and Future DirectionsLONN, Eva; BOSCH, Jackie; TEO, Koon K et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 20, pp 2078-2088, issn 0009-7322, 11 p.Article

MicroRNAs: Regulating a Change of HeartBARRINGHAUS, Kurt G; ZAMORE, Phillip D.Circulation (New York, N.Y.). 2009, Vol 119, Num 16, pp 2217-2224, issn 0009-7322, 8 p.Article

B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective StudiesDI ANGELANTONIO, Emanuele; CHOWDHURY, Rajiv; SARWAR, Nadeem et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 22, pp 2177-2187, issn 0009-7322, 11 p.Article

Diet and lifestyle recommendations revision 2006 : A scientific statement from the american heart association nutrition committeeLICHTENSTEIN, Alice H; APPEL, Lawrence J; KARANJA, Njeri et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 1, pp 82-96, issn 0009-7322, 15 p.Article

High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: The Women's Initiative for Nonsmoking (WINS)SIVARAJAN FROELICHER, Erika S; HOUSTON MILLER, Nancy; BACCHETTI, Peter et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 5, pp 587-593, issn 0009-7322, 7 p.Article

Risk factor criteriaSTAMPFER, Meir J; RIDKER, Paul M; DZAU, Victor J et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 3-5, issn 0009-7322, 3 p., SUPArticle

Inflammatory markers and onset of cardiovascular events: Results from the health ABC studyCESARI, Matteo; PENNINX, Brenda W. J. H; PAHOR, Marco et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 19, pp 2317-2322, issn 0009-7322, 6 p.Article

Genomics in Cardiovascular DiseaseROBERTS, Robert; MARIAN, A. J; DANDONA, Sonny et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 20, pp 2029-2037, issn 0735-1097, 9 p.Article

Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLEVINE, Glenn N; STEINKE, Elaine E; TESSLER LINDAU, Stacy et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 8, pp 1058-1072, issn 0009-7322, 15 p.Article